OAACX
Price
$13.74
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
OAANX
Price
$14.08
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

OAACX vs OAANX

Header iconOAACX vs OAANX Comparison
Open Charts OAACX vs OAANXBanner chart's image
Invesco Active Allocation C
Price$13.74
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Invesco Active Allocation R
Price$14.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
OAACX vs OAANX Comparison Chart
Loading...
VS
OAACX vs. OAANX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OAACX is a StrongBuy and OAANX is a StrongBuy.

FUNDAMENTALS
Fundamentals
OAACX (1.95B) and OAANX (1.95B) have equal amount of cash in the bank . OAANX pays higher dividends than OAACX: OAANX (1.40) vs OAACX (0.94). OAACX was incepted earlier than OAANX: OAACX (19 years) vs OAANX (19 years). OAACX (21.00) and OAANX (21.00) have comparable annual turnover. OAACX (1000) and OAANX (1000) have matching initial minimum investment requirements. OAANX (14.13) and OAACX (13.47) have marching annual gain over last year. OAANX return over 5 years is better than : 2.16 vs. OAACX (-0.97).
OAACXOAANXOAACX / OAANX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years19 years-
Gain YTD8.0198.39196%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.95B1.95B100%
Annual Yield % from dividends0.941.4067%
Returns for 1 year13.4714.1395%
Returns for 3 years-11.47-9.90116%
Returns for 5 years-0.972.16-45%
Returns for 10 years21.3327.3078%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLAB126.153.35
+2.73%
Mesa Laboratories
GL106.650.47
+0.44%
Globe Life
XFOR0.70N/A
+0.06%
X4 Pharmaceuticals
WAFD36.07-0.26
-0.72%
WaFd
GTBP2.18-0.07
-3.11%
GT Biopharma